Clinical Trial Update: Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity

View source ↗

Summary

This clinical trial update reports the completion of a study collecting data on Fabry disease patients with enhanceable alpha-galactosidase A activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Fabry Disease | Status: COMPLETED